Healthline: Rates of IBD including Crohn’s Disease are three times higher than realized
UC digestive diseases expert discusses treatment options
A journalist for Healthline spoke with Loren Brook, MD, an assistant professor in the UC Department of Internal Medicine, about possible treatments for inflammatory bowel disease (IBD). In 2015, more than 3 million U.S. adults reported a diagnosis of IBD, an ongoing inflammation of all or part of the digestive tract, and includes two conditions, Crohn’s Disease and ulcerative colitis.
Brook, also a UC Health physician, explained the disease is usually lifelong but can be managed with relatively minor anti-inflammatory drugs such as oral mesalamine to immune-suppressing medications such as Remicade or steroids.
Related Stories
Can you grow new brain cells?
March 6, 2026
As National Geographic recently reported, a pair of new studies have provided fresh evidence in the long-running scientific debate on if adults can grow new brain cells. The result could be game-changing for treating diseases such as Alzheimer’s and dementia.
Cincinnati’s healthtech startups soar with state funding
March 6, 2026
Four Cincinnati-based healthtech startup ventures earned significant grants from the state of Ohio, fueled by expert guidance and resources at UC’s 1819 Innovation Hub.
Using GLP-1s for weight loss, maintenance after bariatric surgery
March 5, 2026
Bariatric surgery has become a cornerstone treatment for severe obesity and its related comorbidities, offering superior long-term efficacy compared with lifestyle and pharmacologic interventions alone. Yet persistent clinical gaps remain in a subset of patients, including insufficient weight loss and postoperative weight regain.